Navigation Links
MAP Pharmaceuticals Receives Complete Response Letter from FDA for LEVADEX® (dihydroergotamine) NDA
Date:3/26/2012

he webcast, please visit the Company's website at www.mappharma.com  and go to the Investor Relations page. A replay of the webcast will be available approximately two hours after the call.

About MAP Pharmaceuticals

MAP Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new therapies to address undermet patient needs in neurology. The Company is developing LEVADEX®, an orally inhaled investigational drug for the acute treatment of migraine. The New Drug Application for LEVADEX is currently under review by the U.S. Food and Drug Administration. MAP Pharmaceuticals has entered into a collaboration agreement with Allergan, Inc. to co-promote LEVADEX to neurologists and pain specialists in the U.S. and Canada. The Company also applies its proprietary drug particle and inhalation technologies to generate new pipeline opportunities by enhancing the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.

LEVADEX and TEMPO are trademarks of MAP Pharmaceuticals, Inc.

Forward-Looking Statements

In addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to MAP Pharmaceuticals' LEVADEX product candidate. Actual results may differ materially from current expectations based on risks and uncertainties affecting the company's business, including, without limitation, risks and uncertainties relating to the regulatory approval process for the Company's LEVADEX product candidate. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or ob
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2011 Financial Results
2. Pharmaceuticals: Global Industry Guide
3. Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as Chief Commercial Officer
4. JacksonWhite Files Overtime Lawsuit Against Sunovion Pharmaceuticals
5. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results and Reviews Recent Developments
6. Omnicell to Exhibit at Dubai International Pharmaceuticals and Technologies Conference and Exhibition
7. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Wednesday, March 14
8. Auxilium Pharmaceuticals to Present at the 2012 Barclays Capital Global Healthcare Conference
9. S1 Pharmaceuticals Announces New Executive Management and Scientific Advisory Board Appointments
10. Questcor Pharmaceuticals to Present at the 24th Annual ROTH Conference on March 12, 2012
11. Patented Protection Against Counterfeit Pharmaceuticals and Retail Fraud. ICAP Patent Brokerage Announces for Auction a Patented System for Verification of Purchase and Product Legality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Research and Markets ( ... "Medical Device Outsourcing - Global Strategic Business ... This report analyzes the worldwide markets for Medical ... Device Categories: Class I, Class II, and Class ... report Include - Radiology, Orthopedic, Neurology, Cardiology, and ...
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/lmsnqn/medical_equipment ... Equipment Rental and Leasing - Global Strategic Business Report" ... analyzes the worldwide markets for Medical Equipment Rental and ... analytics for the US, Japan , ... Annual estimates and forecasts are provided for ...
(Date:4/17/2015)... , April 17, 2015 ASSESS ... mutation   is a viable alternative to tumour biopsy   ... in all patients with advanced NSCLC   AstraZeneca ... of plasma circulating tumour DNA (ctDNA) testing for epidermal growth ... advanced non-small cell lung cancer (NSCLC) in clinical practice. [ ...
Breaking Medicine Technology:Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 2Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 3Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4
... 2011 OncologyRx Care Advantage, McKesson Specialty Health ... by Incyte Corporation as one of only ... to fill prescriptions for Jakafi (ruxolitinib), an oral prescription ... (Logo:  http://photos.prnewswire.com/prnh/20110912/DA65711LOGO ) ...
... Solos Endoscopy, Inc.,s (OTCPK: SNDY) is pleased to ... Net Profit of $73,895.  Solos Endoscopy has consummated agreements ... for the Three Months period ending September 30, 2011. ... in a reduction of ongoing expenses by approximately $40,000 ...
Cached Medicine Technology:OncologyRx Care Advantage™ Chosen to Fill Prescriptions for Jakafi™ (ruxolitinib) 2Solos Endoscopy Finishes the 3rd Quarter With a Net Profit 2
(Date:4/19/2015)... Family and friends of Brad Baddeley are ... of Brad Baddeley event to honor his memory and ... for Brains is cheduled to take place on Sunday, April ... Lincoln, Nebraska. Participants may arrive at 12:30pm on the 26th ... cost is only $4 per game and 100% of the ...
(Date:4/18/2015)... Hills, CA (PRWEB) April 19, 2015 For ... and will proudly display for the rest of their lives, ... money obtaining them and put in a great amount of ... on a whim, they have outgrown them or simply want ... percent of people regret their tattoo, and in 2012-13 there ...
(Date:4/18/2015)... 2015 Compare-autoinsurance.org has released a new ... auto insurance policy . , Clients should no ... quotes online is safe and reliable. An insurance brokerage ... are displayed on a single web page, so drivers ... It is now possible to compare online car insurance ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Carinsurancesavings.biz has ... insurance plans are cheaper during Spring. , ... auto insurance plan. Drivers should make sure they compare ... their vehicles. Clients can learn more about Spring car ... , Auto insurance quotes are becoming more and ...
(Date:4/18/2015)... PITTSBURGH, PA (PRWEB) April 18, 2015 ... store evacuation stretchers in healthcare facilities," said an inventor ... an alternative storage system." , He developed the Slyde ... bathroom doors used in healthcare facilities. It provides convenient ... that there are more stretchers available for patients. ...
Breaking Medicine News(10 mins):Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 3Health News:Dennis Dass, M.D. is Shattering the Past While Revealing the Future 2Health News:A Guide For Avoiding Online Auto Insurance Scams! 2Health News:Auto Insurance Plans Are Cheaper During Spring! 2
... new and efficient strategy, using eggs alone, for creating ... the risk of rejection because the cells are compatible ... mice, the work establishes the principle of using unfertilized ... that are genetically matched to the egg donor at ...
... infected with lymphocytic choriomeningitis virus (LCMV), an infectious agent ... cause severe brain damage in a fetus. ... winter months, when rodents seek shelter in homes, said ... the University of Iowa Roy J. and Lucille A. ...
... Hospital reporting systems may significantly under-report patient safety incidents, ... on bmj.com today//. ,The authors suggest that the ... be sufficient if the NHS is to gather accurate ... safety incidents. ,Patient safety incidents are common ...
... could bankrupt the health system, warn doctors in this week’s ... population is overweight and more than one in five adults ... at high risk of multiple health problems, while the cost ... at up to 9%, and the overall social cost of ...
... past two decades are leading to more definitive diagnoses, ... for patients suffering from a condition called acromegaly. ... for Academic Affairs and director of the Burns and ... medical progress related to the condition that stems from ...
... vaccine, will hold a pride of place in the annals ... to receive certification by the European Medicines Agency, for its ... bird-flu pandemic. , ,This first generation vaccine can ... officially declares a pandemic. ,A second –generation vaccine ...
Cached Medicine News:Health News:Researchers Create Genetically-Matched Embryonic Stem Cells for Transplantation 2Health News:Researchers Create Genetically-Matched Embryonic Stem Cells for Transplantation 3Health News:Pregnant Women Can Minimize Risk Of Rodent-Based Virus 2Health News:Hospitals Miss Most Patient Safety Incidents 2Health News:Obesity Could Bankrupt the Health System, Warn Doctors 2Health News:Options Improving for Patients With Acromegaly and Gigantism 2Health News:Options Improving for Patients With Acromegaly and Gigantism 3
The DBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of direct (conjugated) bilirubin in serum and plasma....
For the quantitative in vitro determination of Anti-Streptolysin-O (ASO) in serum...
Latex agglutination slide test for the qualitative and semi-quantitative determination of Anti-Streptolysin O (ASO) in human serum...
For the quantitative in vitro determination of IgA in serum and plasma. This product is suitable for use on Hitachi 704, 705, 717, 902, 911 and 912....
Medicine Products: